|
Market Cap (21-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 31 August 2021, 8:21. The announcement is not marked as price sensitive, and is 11 page(s) in length and 176.95kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.017% short sold according to ASIC data. It was ranked the 544th most shorted stock on the ASX. It remains ranked 544th as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Corporate Governance Statement | 31 August 2021, 8:21 |
| Appendix 4E | 31 August 2021, 8:15 |
| Annual Report to shareholders | 31 August 2021, 8:12 |
| MDC Receives Approval for NanaBis PIII Trials from the TGA | 25 August 2021, 9:15 |
You must be logged in to post a reply.
Medlab Clinical 